[82lsju]

AstraZeneca has received more than $1 billion from the U.S. Health Department’s Biomedical Advanced Research and Development Authority to develop a coronavirus vaccine from the University of Oxford. 


The British-Swedish drugmaker has agreed to initially supply at least 400 million doses of the vaccine and secured total manufacturing capacity to produce 1 billion doses, with first deliveries in September. 

AstraZeneca’s development program of the vaccine includes a phase three clinical trial with 30,000 participants and a pediatric trial.

[82lsju]

AstraZeneca has received more than $1 billion from the U.S. Health Department’s Biomedical Advanced Research and Development Authority to develop a coronavirus vaccine from the University of Oxford. 


The British-Swedish drugmaker has agreed to initially supply at least 400 million doses of the vaccine and secured total manufacturing capacity to produce 1 billion doses, with first deliveries in September. 

AstraZeneca’s development program of the vaccine includes a phase three clinical trial with 30,000 participants and a pediatric trial.

[BostonCard]

It's all about shots on goal.

BC

[BostonCard]

It's all about shots on goal.

BC